The first chapter describes a development of the pharmaceutical industry and its market. The attention is especially paid to the pharmaceutical industry of France which is considered to be a representative of the European pharmaceutical industry. The second chapter is focused on the pharmaceutical company marketing and a medicament regarded as a product and presented from its creation to a distribution to a final consumer.

Thesis is focused on drug system development in Czech Republic during years 2000 to 2008, on study of present circumstances and on key features comparison with its development in selected European countries. Author has described drug system functioning, its participants and relations among them set to Czech Republic. Attention is paid especially to sources of rise in prices of drugs and to growth in consumption, then to safety and awareness of current medication. Factors effecting total expenses on drugs are investigated and participation of total expenses on drugs on total health expenses is analyzed. Due to the international comparison there is pronounced conviction that the increase in drug expenses has become a global phenomenon of todays which is to be solved. Great emphasis is placed on questionable segments of drug policy in Czech Republic and on potentials of its improvements in this performance, too.

The diploma thesis deals with a comparison of B2B marketing tools of the biggest pharmaceutical distributors on the Czech market. Alliance Healthcare is one of the leading distributors in this area and would like to increase its turnover and gain new clients. The aim of the thesis is to define marketing tools of all pharmaceutical distributors, make a questionnaire based on this topic that will be sent to customers of the biggest companies and find out how the particular tools are evaluated by the pharmacies and what the position of Alliance Healthcare in comparison to its competitors is. After the evaluation of the questionnaire recommendations that could help Alliance Healthcare to reach its goal follow.

The aim of my thesis is to propose a financing structure for the selected company and then process the credit application. The first part is focused on the strategy of the bank, lending products and the risks that the bank undertakes. Also contains a description of the credit process - the calculation of a credit rating, financing structuring, collateral, covenants determination and processing of credit application. The thesis analyses the specifics of the pharmaceutical industry. Theoretical knowledge is applied to the example of financing of pharmaceutical company and the preparation of a credit application.

The principle behind outsourcing is that an organization outsources tasks it strategically elects not to do within the organization. It is estimated that outsourcing has become a $4 trillion a year business (Corbett, 2005). In today's competitive healthcare marketplace, many sponsors outsource functions that were once considered core to the organization. U.S. Census data show that 10% of all business-to-business sales originated from outsourced sales (Rogers, 2008). The objective of engaging in outsourcing of sales is to improve sales efficiency and gain an edge in today's challenging market. Competition within the pharmaceutical industry coupled with increased regulatory uncertainties and cost concerns have necessitated outsourcing of sales to maintain competitiveness and to apply internal resources more effectively. This research will contribute to the current available works specific to the outsourcing of pharmaceutical sales.

Cílem této práce je vypracovat strategii vstupu produktu "A" farmaceutické společnosti "F" na český a slovenský trh. V této práci je tato strategie analyzována a hodnocena pomocí metody NPV (Net Present Value) a dalších metod. Na základě tohoto hodnocení je strategie vybrána. První kapitola zahrnuje teoretická východiska jednotlivých metod použitých pro účely této práce. Je zde zejména osvětlena metoda NPV a metody vhodné pro analýzu relevantních trhů, společnosti "F" produktu "A". Ve druhé kapitole je provedena analýza trhu České a Slovenské republiky a také analýza společnosti "F" a produktu "A". Tyto analýzy zahrnují jak vnitřní tak vnější potenciál společnosti i produktu. V závěrečné kapitole je vypracována navrhovaná strategie vstupu pro produkt 'A', jež je poté ekonomicky hodnoceny pomocí modelu NPV a dalších modelů.

Aktuell gibt es unterschiedliche Trends in der pharmazeutischen Industrie. Die Herstellung von API´s wird zunehmend bei den Herstellern der finalen Produkte vorgenommen. BIG Pharma integriert die API Herstellung in House. Die Batchproduktion geht tendenziell zu immer kleinen Volumen mit speziellen Anwendungsbereichen. Produkte mit größerem Volumen werden vom Batchvolumen in eine kontinuierliche Produktion überführt und speziell auch auf diese neue Herstellungstechnologie entwickelt. Die Anforderungen für diese unterschiedlichen Applikationen sind völlig unterschiedlich.

This diploma thesis describes and analyzes an area of competitive intelligence in the pharmaceutical industry. The work is divided into five parts. The first part deals with competitive intelligence and related aspects, the second part is dedicated to the pharmaceutical industry, with all specifics. The third part deals with competitive intelligence in the intersection with the pharmaceutical industry, the fourth part contains the classification and description of information resources appropriate for the activities of CI and a fifth part presents research, which consists of a questionnaire survey among pharmaceutical companies on the state of competitive intelligence and semi-structured interview with an expert in the area of CI in pharmaceutical company. The survey results represent a certain sub-probe, which demonstrates the strong position of CI as a common standard of pharmaceutical companies. Keywords competitive intelligence, pharmaceutical industry, information needs, drugs, pharmacovigilance, patents, information resources

The purpose of this study is to conceptualize the ideational influence of Ordoliberalism on EU Competition Law while addressing a problematic social issue that has been witnessing a surge in the number of cases, which is excessive price abuse under Article 102(a) of the Treaty on the Functioning of the European Union (TFEU) within the spectrum of pharmaceutical sector. By utilizing Nedergaard (2020)’s analytic framework for Ordoliberalism’s operationalization, the study successfully proves the impacts of five characteristics of Ordoliberalism, including Politics by rules, Economic Constitution, Market Construction, Role of Consumers and Role of the states towards consumers, on the practices of EU Competition Law, using the empirical data collected from two excessive pricing examples: Aspen in Italy and Pfizer/Flynn in the United Kingdom. The study also highlights the unique features of the pharmaceutical market due to its significant impacts on public healthcare and medicine assessment. At the end of the study, some recommendations are provided for further investigations.

Magister Commercii (Industrial Psychology) - MCom(IPS) / In the 21st century the nature of work and life has become characterized by unavoidable changes. These changes are brought about by various environmental, social and technological developments or unforeseen occurrences. It has become more challenging for economies, countries and organizations to bounce back from these volatile fluctuations in all markets and industries (Martine & Alves, 2015). Examples of the above-mentioned changes is emphasized by Wales (2013) who identified that trends such as climate change, globalization and social inequality have created a significant challenge to the traditional business model. The “credit crunch”, corporate scandals and possible corruption have led to a loss of trust in business, and companies are facing pressures from governments, consumers, employees and investors to demonstrate that they are adopting ethical and sustainable business practices (Pfeffer, 2015). Similarly, Martine and Alves (2015) question whether the economy, society and environment in the 21st century are indeed the three pillars of sustainability. These factors highlight the importance of critically discussing factors surrounding economic growth and the sustainability thereof.